Pain Therapeutics reported $-17508000 in EBITDA for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Abbott ABT:US $ 3735M 316M
Acelrx Pharmaceuticals ACRX:US $ -8.57M 0.86M
Acura Pharmaceuticals ACUR:US -282000 154K
Amgen AMGN:US $ 3341M 185M
Biogen BIIB:US $ 674.7M 20.2M
Cara Therapeutics CARA:US $ -27848000 5.61M
Eisai 4523:JP Y -11598M 35133M
Eli Lilly And LLY:US $ 3005.6M 161.6M
Geron GERN:US $ -28.62M 2.3M
Johnson & Johnson JNJ:US $ 9309M 1549M
Merk MRK:US $ 6179M 492M
Novartis NOVN:VX SF 4552M 346M
Novavax NVAX:US $ 216.06M 1037.12M
Pain Therapeutics PTIE:US $ -17.51M 3.38M
Pfizer PFE:US $ 11182M 4046M